Notch Signaling Pathway
The Notch signaling pathway is a conserved metazoan juxtacrine (cell-contact-dependent) signaling mechanism in which both the transmembrane receptors (Notch1–4 in mammals) and their canonical transmembrane ligands (Delta-like [DLL1, DLL3, DLL4] and Jagged [JAG1, JAG2]—collectively termed DSL [Delta/Serrate/LAG-2] ligands) are anchored in the plasma membranes of directly adjacent cells.
The Notch signaling pathway is a conserved metazoan juxtacrine (cell-contact-dependent) signaling mechanism in which both the transmembrane receptors (Notch1–4 in mammals) and their canonical transmembrane ligands (Delta-like [DLL1, DLL3, DLL4] and Jagged [JAG1, JAG2]—collectively termed DSL [Delta/Serrate/LAG-2] ligands) are anchored in the plasma membranes of directly adjacent cells. First identified in Drosophila melanogaster by John Dexter (1914) and Thomas Hunt Morgan (1917) via X-linked haploinsufficient mutations that produced serrated "notches" along the wing margin—and cloned by Spyros Artavanis-Tsakonas and Michael Young in the 1980s—Notch signaling operates without soluble second messengers or intracellular kinase amplification cascades.
Instead, receptor activation relies on mechanotransduction: E3 ubiquitin-ligase-driven endocytosis of the DSL ligand into the signal-sending cell exerts a 4–12 piconewton mechanical pulling force on the Notch ectodomain of the signal-receiving cell, unfolding a juxtamembrane Negative Regulatory Region (NRR) to expose cleavage sites for ADAM10 metalloprotease (S2 cleavage) and intramembrane γ-secretase (S3 cleavage). The liberated Notch Intracellular Domain (NICD) translocates directly into the nucleus, where it converts the DNA-bound transcription factor CSL (RBPJ) from a transcriptional repressor into an activator, driving lateral inhibition, binary lineage specification (such as T-cell vs. B-cell fate), arterial endothelial tip-vs.-stalk sprouting, and the vertebrate somite segmentation clock.
Receptor Maturation, O-Glycosylation, and Mechanochemical Proteolysis
1. Fringe Glycosylation Code: Tuning Delta vs. Jagged Sensitivity
The extracellular domain of mammalian Notch1 and Notch2 contains 36 tandem Epidermal Growth Factor (EGF)-like repeats (29 in Notch4; 34 in Notch3). In the endoplasmic reticulum, Protein O-Fucosyltransferase 1 (POFUT1) attaches O-linked fucose to conserved serine/threonine residues within these EGF repeats. As Notch transits the Golgi apparatus, the Fringe family of β-1,3-N-acetylglucosaminyltransferases (Lunatic Fringe [LFNG], Manic Fringe [MFNG], and Radical Fringe [RFNG]) elongates these O-fucose moieties with GlcNAc:
- Fringe-modified Notch exhibits strongly enhanced binding and activation by Delta-like ligands (DLL1, DLL4) while inhibiting activation by Jagged ligands (JAG1). This glycosyltransferase code establishes sharp developmental compartment boundaries (such as the dorsal–ventral boundary of the Drosophila wing imaginal disc and vertebrate rhombomeres).
- Furthermore, whereas trans-interactions between ligand and receptor on opposing cells activate Notch, cis-interactions between DSL ligands and Notch receptors co-expressed on the same cell surface mutually inhibit receptor activation (cis-inhibition), sharpening the binary digital threshold of cell-fate switches.
2. The Nuclear CSL (RBPJ) Transcriptional Switch and PEST Turnover
In the absence of nuclear NICD, the sequence-specific transcription factor CSL (CBF1 / RBPJ in mammals, Suppressor of Hairless [Su(H)] in Drosophila, LAG-1 in Caenorhabditis elegans) sits on target promoters (consensus 5′–CGTGGGAA–3′) bound to corepressor complexes (SHARP/MINT, NCoR/SMRT, KDM5A, and histone deacetylases [HDACs]) that keep chromatin transcriptionally silenced.
Upon S3 cleavage by γ-secretase, the NICD enters the nucleus, where its high-affinity RAM domain and seven Ankyrin (ANK) repeats bind directly to RBPJ, displacing the corepressors and creating a composite groove that recruits the coactivator Mastermind-like (MAML1–3) and the histone acetyltransferase p300/CBP. To ensure that each cleavage event produces only a brief transcriptional pulse, CDK8 phosphorylates the C-terminal PEST domain of NICD during transcription, targeting NICD for immediate recognition by the F-box E3 ubiquitin ligase FBXW7 (Cdc4) and degradation by the 26S proteasome.
Developmental Patterning Paradigms
1. Lateral Inhibition (Neurogenesis and Inner-Ear Hair Cells)
During embryonic neurogenesis, an initially equipotent sheet of neuroepithelial progenitor cells co-expresses both Notch1 and DLL1 alongside proneural basic helix-loop-helix transcription factors (Ascl1 / Mash1, Neurogenin-1/2):
- Stochastic elevation of proneural transcription factors in one cell upregulates DLL1 on its surface.
- This nascent neuroblast strongly activates Notch on all of its immediate neighbors, driving nuclear NICD–RBPJ expression of the bHLH transcriptional repressors HES1 and HES5.
- HES1/HES5 directly repress proneural genes and DLL1 transcription in the neighboring cells, forcing the neighbors to remain uncommitted neural stem cells / radial glia while the high-Delta cell differentiates into a neuron (salt-and-pepper patterning). The identical DLL4–Notch1 lateral inhibition circuit selects a single migrating endothelial tip cell (high VEGFR2, high DLL4) from trailing stalk cells (high Notch1, high VEGFR1) during retinal and tumor angiogenesis.
2. The Vertebrate Somite Segmentation Clock
In the presomitic mesoderm of vertebrate embryos, delayed negative feedback by HES7 (in mammals) or Her1/Her7 (in zebrafish) and Lunatic Fringe (LFNG)—which repress their own promoters until their short-lived mRNAs and proteins decay—generates cell-autonomous ultradian oscillations (with a period of ~30 min in zebrafish, ~90 min in chick, ~2 hours in mouse, and ~5 hours in human embryos) synchronized across neighboring cells by DLL1–Notch1 juxtacrine coupling to bud off sequential pairs of somites (future vertebrae and skeletal muscles).
Human Genetic Syndromes and Oncogenic Activating vs. Tumor-Suppressor Roles
Remarkably, Notch1 acts as a potent proto-oncogene in T lymphocytes (where Notch1 normally drives common lymphoid progenitors toward the T-cell lineage while suppressing B-cell fate) but acts as a tumor suppressor in stratified squamous epithelia (where Notch1 normally drives keratinocyte differentiation and cell-cycle exit via p21CIP1):
| Disease / Malignancy | Mutated Gene(s) | Functional Mechanism | Clinical Phenotype & Targeted Therapy |
|---|---|---|---|
| T-Cell Acute Lymphoblastic Leukemia (T-ALL) | NOTCH1 (>60% of cases) &/or FBXW7 (~15–20%) | Gain-of-function missense mutations destabilize the extracellular NRR/HD domain (triggering ligand-independent S2/S3 cleavage) and/or truncating mutations delete the C-terminal PEST domain (or inactivate FBXW7), stabilizing nuclear NICD1 to drive MYC transcription. | Aggressive T-lymphoblast proliferation (mediastinal thymic mass, marrow replacement). Investigated with γ-secretase inhibitors (e.g., nirogacestat, FDA-approved for desmoid tumors). |
| Cutaneous, Head & Neck, and Esophageal Squamous Cell Carcinoma | NOTCH1, NOTCH2, NOTCH3 | Loss-of-function nonsense or EGF-repeat missense mutations abolish Notch-driven suprabasal keratinocyte differentiation, locking basal progenitors in a proliferative state. | High-burden squamous carcinomas (where γ-secretase inhibition paradoxically promotes cutaneous squamous neoplasms). |
| Alagille Syndrome | JAG1 (~94%) or NOTCH2 (~2–4%) | Autosomal dominant haploinsufficiency of Jagged1–Notch2 signaling during embryonic bile duct, pulmonary artery, and vertebral morphogenesis. | Paucity of interlobular bile ducts (neonatal cholestasis/jaundice), peripheral pulmonary artery stenosis, butterfly vertebrae, and posterior embryotoxon of the eye. |
| CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) | NOTCH3 (EGF repeats 1–34) | Stereotyped missense mutations that gain or lose a cysteine residue (leaving an odd number of cysteines: 5 or 7 instead of 6 per EGF repeat) in vascular smooth muscle cells, causing extracellular Notch3 ectodomain aggregation (granular osmiophilic material, GOM). | Migraine with aura in young adulthood followed by recurrent subcortical lacunar strokes and vascular dementia. |
| Spondylocostal Dysostosis | DLL3, MESP2, LFNG, HES7 | Autosomal recessive disruption of the presomitic Notch segmentation clock. | Extensive hemivertebrae, vertebral fusions, and rib anomalies ("crab-like" thorax). |
References
- Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999). Notch signaling: cell fate control and signal integration in development. Science, 284(5415), 770–776. Google Scholar
- Kopan, R., & Ilagan, M. X. G. (2009). The canonical Notch signaling pathway: unfolding the activation mechanism. Cell, 137(2), 216–233. Google Scholar
- Bray, S. J. (2016). Notch signalling in context. Nature Reviews Molecular Cell Biology, 17(11), 722–735. Google Scholar
- Siebel, C., & Lendahl, U. (2017). Notch signaling in development, tissue homeostasis, and disease. Physiological Reviews, 97(4), 1235–1294. Google Scholar